MR Antagonist and LSD1

Clinical trial NCT04840342 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04840342
Sponsor: Brigham and Women's Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Mineralocorticoid Excess

Start date: 2022-02-03
Primary completion: 2025-09-15
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.